Atıf Formatları
Prostate cancer: finasteride extends PSA doubling time during intermittent hormone therapy EDITORIAL COMMENT
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

L. Turkeri, "Prostate cancer: finasteride extends PSA doubling time during intermittent hormone therapy EDITORIAL COMMENT," CANADIAN JOURNAL OF UROLOGY , vol.17, no.3, pp.5169, 2010

Turkeri, L. 2010. Prostate cancer: finasteride extends PSA doubling time during intermittent hormone therapy EDITORIAL COMMENT. CANADIAN JOURNAL OF UROLOGY , vol.17, no.3 , 5169.

Turkeri, L., (2010). Prostate cancer: finasteride extends PSA doubling time during intermittent hormone therapy EDITORIAL COMMENT. CANADIAN JOURNAL OF UROLOGY , vol.17, no.3, 5169.

Turkeri, LEVENT. "Prostate cancer: finasteride extends PSA doubling time during intermittent hormone therapy EDITORIAL COMMENT," CANADIAN JOURNAL OF UROLOGY , vol.17, no.3, 5169, 2010

Turkeri, LEVENT. "Prostate cancer: finasteride extends PSA doubling time during intermittent hormone therapy EDITORIAL COMMENT." CANADIAN JOURNAL OF UROLOGY , vol.17, no.3, pp.5169, 2010

Turkeri, L. (2010) . "Prostate cancer: finasteride extends PSA doubling time during intermittent hormone therapy EDITORIAL COMMENT." CANADIAN JOURNAL OF UROLOGY , vol.17, no.3, p.5169.

@article{article, author={LEVENT TÜRKERİ}, title={Prostate cancer: finasteride extends PSA doubling time during intermittent hormone therapy EDITORIAL COMMENT}, journal={CANADIAN JOURNAL OF UROLOGY}, year=2010, pages={5169} }